Water-Free Dosing: What Changes for Travel and Training

▶ Watch the video

By Jack Zheng, MS Pharmacy — Founder of MIHIYO Labs

Summary

Water-free dosing changes more about the practical act of taking a supplement than most labels acknowledge. In a general-practice survey of 1,051 adults, 37.4 percent reported difficulty swallowing tablets or capsules — a problem that can persist even when water is available, shaped by both patient and dosage-form factors. Add settings where water is inconvenient to reach — mid-workout, on transit, between meetings — and a pill's dependence on water becomes a second point of friction. An oral dissolving strip (ODS) dissolves directly against oral tissue, so there is no intact tablet or capsule to swallow and no added fluid required. MIHIYO Labs builds its Energy-Focus strip around that constraint.

Does it actually matter that a supplement doesn't need water?

Customers ask me this as if it were a convenience question, and I understand why — on paper, a glass of water sounds like a trivial requirement. In practice, it is two separate constraints stacked on top of each other. The first is mechanical: a meaningful share of adults find swallowing solid tablets or capsules genuinely difficult, independent of whether water is available. In a general-practice survey of 1,051 adults, 37.4 percent reported having had difficulty swallowing tablets or capsules, and 70.4 percent of those people had never mentioned it to their physician.¹ The second constraint is situational: even someone with no swallowing difficulty at all still needs a source of water, at the right moment, to take a pill as directed. An oral dissolving strip removes both constraints by removing the dependency itself — no intact tablet or capsule to swallow, and no water to find. That is the design logic behind water-free dosing, and it is worth separating from marketing language about "convenience," because the underlying constraints are specific and practical.

Why doesn't an oral dissolving strip need water to work?

A swallowed tablet or capsule is built around the assumption that water will carry it to the stomach, where it disintegrates and releases its contents into the gastrointestinal tract for absorption. Many conventional tablets and capsules are taken with water to help them pass through the esophagus and reach the stomach comfortably — without it, a pill can be harder to swallow or slower to clear the mouth and throat. An oral dissolving strip works on a different mechanism entirely: it is a thin polymer film placed on the tongue or against the inner cheek, where saliva — not added water — dissolves it directly. I target a dissolve window of roughly 30 to 60 seconds of sustained contact with oral tissue. During that contact time, some active ingredients may have the opportunity for absorption across the oral mucosa, depending on their physicochemical properties and how the formulation is built — mucosal absorption that, when it happens, can bypass part of the hepatic first-pass metabolism that swallowed forms go through. Whether that absorption occurs at all, and how much of it happens, depends on the specific molecule, the formulation, and the site of contact; the mucosa's own permeability is itself a real limiting factor, not just a doorway.² Saliva provides the fluid needed to hydrate and dissolve the film, while the underlying oral mucosa provides a potential absorption surface for suitable active ingredients — a customer does not need to plan around anything except opening the pack.

That is a genuinely different mechanism from most "fast-dissolving" tablets on the market, and the distinction matters enough that I want to be precise about it. An orally disintegrating tablet (ODT) — the format used for some prescription and OTC products — is engineered to fall apart quickly in the mouth, but the resulting material is typically swallowed and absorbed through the gastrointestinal tract, the same route as a conventional tablet. In vitro bioequivalence modeling for ODTs has incorporated the possibility that ODTs taken without water may experience slower gastric emptying than conventional tablets taken with water, potentially delaying time to peak plasma concentration, because the disintegrated material still has to transit the stomach on its own — that is a modeling result, not a human pharmacokinetic trial.³ An ODT solves the "do I need a glass of water" problem; it does not, on its own, change the absorption route. MIHIYO's oral dissolving strip solves the water problem the same way. Because the film is designed for sustained contact with oral tissue rather than the seconds-scale disintegrate-and-swallow behavior of an ODT, it may also provide an opportunity for some transmucosal absorption, depending on the active ingredient's own properties and how the film is formulated. Most conventional ODTs, by contrast, are designed primarily for rapid oral disintegration followed by swallowing rather than for transmucosal delivery — though the dosage-form name itself doesn't rule out some absorption for any given ODT formulation. I'm not claiming a specific degree of transmucosal absorption happens for MIHIYO's own strips absent product-specific testing.

What does the data show about water-dependent dosing failure points?

Swallowing difficulty and travel or exercise disruption are two different bodies of evidence, and I want to keep them distinct rather than blend them into one vague "convenience" argument. Start with swallowing itself: the 37.4 percent figure above comes from an unselected general-practice population of adults taking solid oral dosage forms, not from a cohort selected specifically for dysphagia — a relevant comparison for an over-the-counter supplement, though it does not mean the sample excluded people who already have a swallowing disorder. A separate, later point-prevalence study of acute hospital inpatients found a lower but still real 15.4 percent rate of swallowing difficulty in that different population, which is useful cross-validation that the underlying phenomenon shows up across settings, even though the two numbers describe different groups and shouldn't be averaged together.⁴

Travel-related routine disruption has its own evidence base. Water availability during travel or exercise is a separate practical consideration, without the same direct research behind it. A 2024 interview study of older adults managing daily prescription medications found that routine disruption — travel chief among the examples participants raised — was one of the most common reasons a dose got missed, because travel removes the environmental cues (a specific room, a specific meal, a specific cup by the sink) that a medication routine normally runs on autopilot around.⁵ That study was about prescription adherence in a small qualitative sample, not supplement use, so I'm citing it for the mechanism — disrupted routines break dosing cues — rather than for a number that would transfer directly to MIHIYO customers, and it does not show that a lack of water specifically was the reason doses were missed. Exercise raises a related but distinct issue, and I want to be careful not to overstate the connection. A systematic review of exercise-induced dehydration found that perceived exertion rises by roughly 0.21 points for every 1 percent of body mass lost, although the average effect remained relatively small across the levels of dehydration studied.⁶ That research says nothing about whether people ration water specifically to avoid spending it on pill-taking, or whether a supplement's water requirement measurably affects anyone's hydration status. The more honest, more limited point is about access, not fluid budget: during a workout, a bottle or fountain may simply not be within reach at the exact moment someone wants to take a dose, independent of any hydration strategy.

What this means for MIHIYO's Energy-Focus strip

Energy-Focus is the product where the water-free argument matters most in practice because it is designed for situations such as pre-workout use, transit, or the moments before a meeting, when having water immediately available may be inconvenient. When I was setting the film's dissolve target at 30 to 60 seconds, one of the situations I was designing against directly was a customer standing at a trailhead, mid-set at a gym, or three rows back on a plane with no cup of water and no interest in finding one — a caffeine tablet that is typically taken with water is a worse fit for that moment than the pharmacology alone would suggest. The packaging follows from the same logic: a single foil-wrapped strip that fits in a pocket or a gym-bag pouch, with no pill case, no water bottle, and no need to remember which compartment holds today's dose.

I want to be specific about what the caffeine-delivery-film literature does and doesn't support here, because it would be easy to overstate. A 2019 study administered a rapidly dissolving oral film containing micronized caffeine to mice and found it produced higher serum caffeine levels at 1, 10, and 30 minutes, and faster suppression of EEG delta and theta wave activity, compared with the same caffeine dose given by oral gavage.⁷ That is a rodent pharmacokinetic study, not a human trial, and gavage is not equivalent to a person swallowing a capsule with water — so I am not citing it as proof of a specific onset-time advantage for MIHIYO's Energy-Focus strip in people. The study was also conducted under an industry-sponsored research agreement, with two of the authors serving as consultants to the film manufacturer — properly disclosed in the paper, and not a reason to doubt the measurements, but worth naming rather than leaving implicit. What the study does support, at the level of mechanism, is the same principle behind the buccal-permeability data above: in that mouse model, a film-based oral delivery route produced earlier systemic caffeine exposure than oral gavage. Readers who want the human onset-time data specifically — Tmax figures for caffeine across dosage forms — should see the separate breakdown I've written on how fast caffeine strips actually work and the general onset-time framework I use across MIHIYO's product line. The Energy-Focus strip itself is formulated as one fixed daily caffeine dose specifically so that removing the water requirement doesn't also require the customer to make a dosing judgment call in the same inconvenient moment.

Where does water-free dosing fall short?

This argument has real limits, and I'd rather state them plainly than let the water-free framing oversell itself. First, removing the water requirement does not mean removing water from the picture entirely — general hydration still matters for health and for exercise performance on its own terms, and nothing about an oral strip changes a person's actual fluid needs; it only removes water as a precondition for taking the dose itself. Second, the swallowing-difficulty data I cited describes solid tablets and capsules broadly, not caffeine or supplement products specifically, and it does not tell us how many people who have no trouble swallowing pills would still prefer a water-free format for convenience alone — those are two different customer populations, and I don't have data separating them. Third, the ODT bioequivalence research and the mouse caffeine-film study both describe mechanisms adjacent to what MIHIYO's strips do, not measurements of MIHIYO's own products; I'm using them to explain why the format is designed the way it is, not as evidence that any specific MIHIYO strip has been tested for onset time or bioavailability in a clinical trial. Fourth, oral residence time is still a real constraint: swallowing the dissolved material quickly reduces its contact time with oral tissue and may reduce the opportunity for transmucosal absorption, so the mucosal-absorption advantage only applies to the fraction of the dose actually held against tissue for the intended window — a customer who swallows quickly, drinks, or eats immediately after placing the strip gets less of that opportunity.

The bottom line

Water-free supplement dosing solves two distinct problems, and both are real: a meaningful share of adults find swallowing solid pills difficult regardless of water access, and travel, training, and transit can create situations where water is inconvenient or not immediately available at the moment a dose is due. An oral dissolving strip removes both dependencies by dissolving directly against oral tissue rather than requiring a swallow-and-transit route, and for MIHIYO's Energy-Focus strip specifically, that design choice targets the exact situations the product is intended for — pre-workout, mid-commute, or between meetings — where having water immediately available may be inconvenient. None of this replaces good hydration habits or turns a strip into a clinically validated faster-onset product; it removes one specific, practical point of friction from the act of taking a dose at all.

References

1. Schiele, J.T., Quinzler, R., Klimm, H.D., Pruszydlo, M.G., Haefeli, W.E. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. European Journal of Clinical Pharmacology. 2013;69(4):937-948. PMID: 23052416. DOI: 10.1007/s00228-012-1417-0
2. Wanasathop, A., Patel, P.B., Choi, H.A., Li, S.K. Permeability of Buccal Mucosa. Pharmaceutics. 2021;13(11):1814. PMID: 34834229. DOI: 10.3390/pharmaceutics13111814
3. Takagi, T., Masada, T., Minami, K., Kataoka, M., Yamashita, S. Development of an In Vitro Methodology to Assess the Bioequivalence of Orally Disintegrating Tablets Taken without Water. Pharmaceutics. 2023;15(9):2192. PMID: 37765162. DOI: 10.3390/pharmaceutics15092192
4. Harnett, A., Byrne, S., O'Connor, J., Burke, E., South, L., Lyons, D., Sahm, L.J. Point Prevalence Survey of Acute Hospital Patients with Difficulty Swallowing Solid Oral Dose Forms. Pharmaceutics. 2024;16(5):584. DOI: 10.3390/pharmaceutics16050584
5. Gualtieri, L., Rigby, M., Wang, D., Mann, E. Medication Management Strategies to Support Medication Adherence: Interview Study With Older Adults. Interactive Journal of Medical Research. 2024;13:e53513. PMID: 39137021. DOI: 10.2196/53513
6. Deshayes, T.A., Pancrate, T., Goulet, E.D.B. Impact of dehydration on perceived exertion during endurance exercise: A systematic review with meta-analysis. Journal of Exercise Science & Fitness. 2022;20(3):224-235. PMID: 35601980. DOI: 10.1016/j.jesf.2022.03.006
7. Hines, R.M., Khumnark, M., Macphail, B., Hines, D.J. Administration of Micronized Caffeine Using a Novel Oral Delivery Film Results in Rapid Absorption and Electroencephalogram Suppression. Frontiers in Pharmacology. 2019;10:983. PMID: 31551785. DOI: 10.3389/fphar.2019.00983

By Jack Zheng, MS Pharmacy — Founder of MIHIYO Labs. Focused on the R&D of high-bioavailability, fast-absorption oral dissolving strips.